Explained herein are pharmaceutical packaging units which avert oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate medicine, such systems which include a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with quite reduced permeability to oxygen and compri